Summary 31P-NMR surface coil spectra of three subcutaneously implanted rat tumours (Morris hepatoma 7777, GH3 prolactinoma, Walker carcinosarcoma) and an N-methyl-N-nitrosourea induced rat mammary adenocarcinoma at different stages of growth were obtained and compared with histological sections taken immediately after NMR acquisitions. Metabolite ratios (phosphocreatine (PCr)/Pnucleoside triphosphate (PNTP), PCr/Pi, PNTP/Pi) calculated from the NMR spectra were compared with ratios obtained from acid extracts of tumours of similar size. Measurements of creatine and ADP were also made. Three of the tumours showed positive correlations between increasing tumour size and decreasing metabolite ratios measured both by NMR and in extracts, whereas the Walker carcinosarcoma showed no correlation between size and any parameters measured. Phosphorus metabolite ratios, measured in extracts of skin overlying the tumours, indicated a fall in high energy phosphate when there was histological evidence of skin invasion by the tumour. Surface coil 31P-NMR spectra of subcutaneously grown or induced tumours in the rat represent a slowly changing steady state as the tumour increases in size. We conclude that increasing numbers of hypoxic tumour cells, rather than large areas of necrotic tissue, contribute largely to the NMR spectrum.
3'P-NMR spectroscopy has been used to monitor growth and response to therapy in several experimental tumour lines (Ng et al., 1982; Steen et al., 1988; Wehrle et al., 1987; Rodrigues et al., 1988; Tozer et al., 1989) . Tumour response to various types of chemotherapy and X-irradiation therapy often involves the reversal of the changes seen during untreated progression; the treated tumour appears more highly energised (i.e. has increased phosphocreatine/pnucleoside triphosphate (PCr/PNTP), PCr/Pi or PNTP/Pi; see Methods) than before treatment.
The changes in the 3'P-NMR spectra that occur as animal tumours grow could be due to several causes. Most tumours described in the literature have shown a fall in high energy phosphates with increasing age and size which is usually attributed to increasing hypoxic or necrotic fractions (Ng et al., 1982; Rofstad et al., 1988a) . Other factors, such as host cell invasion, oedema, haemorrhage and cyst formation, will also affect the spectrum.
Our recent studies (Stubbs et al., 1988a (Stubbs et al., , 1989 on the contribution of rat skin to surface coil spectra of subcutaneous tumours suggest that this, too, could be important in studies on animals.
If the tumour invades and destroys the skin (and particularly the panniculus carnosus muscle which forms a major part of rodent skin) the skin contribution to the 3'P-NMR spectrum will decrease with increasing tumour size. In order to elucidate these processes we have embarked on a series of studies of tumour growth.
Here we report the results of NMR studies of a variety of subcutaneously implanted rat tumours in vivo, at different time points in their growth, where we have compared the NMR spectra with histological sections of the tumours and with results obtained by hplc and enzymatic assay of acid extracts of the tumours. The tumours studied include Morris hepatoma 7777, the GH3 prolactinoma, the Walker carcinosarcoma and the NMU-induced mammary adenocarcinoma.
In addition we have freeze-clamped and measured phosphate metabolites in acid extracts of the tissues overlying some of the subcutaneous tumours.
There are several difficulties associated with such a study. First, freeze clamping needs to be done rapidly in order to minimise breakdown of high energy phosphates and because (Gadian, 1982; Iles et al., 1985; Freeman et al., 1983) ; see also Results section of this paper). For these and other reasons (including lack of the metabolite in question, poor resolution in the NMR spectrum, etc.), we have compared trends in the energy status of the tumours by means of several different ratios in addition to PCr/NTP. It is assumed that, in tumours that contain adequate creatine kinase activity, there will be an equilibrium relationship between cytosolic PCr, creatine (Cr), NTP and NDP so that PCr/Cr, and NTP/NDP will reflect changes in PCr/NTP; in tumours that do not contain creatine kinase comparisons are limited to NTP/NDP and NTP/Pi.
Preliminary accounts of this work have been presented (Stubbs et al., 1988b, c) .
Methods
Tumours Each batch of tumours (Morris Hepatoma 7777, GH3 prolactinoma, Walker carcinosarcoma; for details of tumours see Stubbs et al., 1989) was grown up from a single inoculum or induced by N-methyl-N-nitrosourea (NMU) injection (mammary adenocarcinoma; see Williams et al., 1981) . There were at least 10 in each batch for the prolactinoma, Walker carcinosarcomas and mammary adenocarcinomas, six in one Morris hepatoma 7777 batch and five in another. Tumours were chosen in pairs in increasing sizes; one for the NMR study which was taken for histology after the completion of the NMR collection and one of similar size which was freezeclamped, acid extracted and assayed for high energy phosphates. Tumour volumes were measured using the formula: V=n/6dl . d2 . d3 NMR measurements The NMR was performed on a 1.89T-TMR 32200 spectrometer with a 27 cm horizontal bore, from Oxford Research Systems, Abingdon, UK. Spectra were obtained from each batch of tumours with a surface coil (Ackerman et al., 1980) , either 1, 1.4 or 2 cm diameter, with a 6, 8 or 10 s pulse duration respectively. The 900 pulses for these coils at the coil centre were 4, 6 and 6 ,is respectively. The repetition time was 3 s and 480 scans were collected routinely. Exponential weighting equivalent to 15 Hz line broadening and deconvolution with a function to reduce broad spectral lines was applied before integration of the peaks using the software package supplied with the machine (for further details see Rodrigues et al., 1988 Measurements ofphosphocreatine, creatine and Pi PCr and Cr were assayed enzymatically on neutralised perchloric acid extracts by the method described in Bergmeyer (1974) and Pi by the method of Lowry and Lopez (1946) as modified by Chandra Rajan and Klein (1976).
Adenine nucleotides These were assayed in neutralised extracts by hplc with a hypersil-APS (5 p) weak anion exchange column and a Waters Instrument. A linear phosphate gradient from 22 mM to 0.7M was used, prepared from Aristar potassium phosphate (Shuttlewood & Griffiths, 1982) .
Histological sections A section, orthogonal to the plane of the coil, was taken through the centre of the tumour, including the skin, immediately after the NMR acquisition. Sections were cut from these specimens and fixed in 25% formal saline and subsequently cut and stained with Haematoxylin & Eosin.
Results

GH3 prolactinoma
The NMR spectra showed seven clear peaks of which only PCr appeared to change consistently with increasing size of tumours (for representative spectra see Figure Comparisons of NMR spectra with acid extracts of the prolactinomas PCr/PNTP ratios calculated from both the peak areas in the NMR spectra and in the acid extracts (Table I) decreased significantly with increasing tumour volume (for correlation coefficients see Table III ).
There was a less marked but still significant decrease in ,BNTP/Pi measured from the NMR spectra. PCr/Cr and NTP/NDP measured in the acid extracts also correlated with the increase in tumour size (Table III) . Cr was consistently present in all sizes of this tumour. Tumour pH calculated from the chemical shift of Pi in the NMR spectrum ranged between 7.1 and 7.5 but showed no correlation with size.
Morris hepatoma 7777
Tumours were studied at various times after implantation when they had reached sizes ranging from 3 to 29 cm3. In the NMR spectra of these tumours the Pi peak increased with size (for two representative spectra see Figure 2 ). No PCr resonance was observed except in the smallest tumour (not shown in Figures) . Histological sections showed that as the tumour grew the cutis became thin and histological evidence of panniculus carnosus muscle, which was present in a tumour of 12.4 cm3 (Figure 2c Comparison of NMR spectra with acid extracts of hepatoma 7777 Since the acid extracts showed no detectable PCr or Cr at any time there is no directly comparable ratio between the NMR and the acid extract data. However, the significant decrease in PNTP/Pi observed with increasing tumour size (for correlation coefficients see Table III ) was mirrored by a fall in the NTP measured in the acid extract from 1.23 tmol g-' in the smallest tumour to 0.6 jmmol g' in the largest tumour and also by a fall in the NTP/NDP ratio. pH varied between 7.1 and 7.6 with no apparent correlation to size of tumour.
NMU-induced mammary adenocarcinomas A distinct PCr resonance was observed in the NMR spectra of three tumours of 1.4, 2.1 and 7.4 cm3. In tumours larger than 7.4 cm3 and in one of 3.9 cm3, the phosphocreatine resonance was negligible (spectra of typical mammary adeno- Table   III ). However, the trend of decreasing high energy phosphates with increasing tumour size was evident, especially in the extract PCr/Cr ratio where it was statistically significant (see also Table III) . Cr was consistently present in this tumour and pH ranged between 7.0 and 7.5.
Walker carcinosarcoma Two batches of tumours (a total of nine) ranging from 2.5 to 27.5 cm3 were examined by NMR. Figure 3a shows the NMR spectrum and Figure 3b the histological section of a tumour (6.2 cm3) in the range studied (2.6-20.4 cm3). Histological sections showed evidence of a granulomatous reaction in the subcutis in response to the presence of implanted tumour cells with some inflammatory cell infiltration of the surrounding tissues (Figure 3b ). In the largest tumour there were large areas of cellular necrosis. There were, however, no differences in the histological structures of the actively growing tumour aggregates. All the acid extracts of the Walker carcinosarcomas studied contained PCr (range 0. 1-1.0 iimol g-' wet wt) and Cr (range 0.5-2.8 tmol g-' wet wt) but some had strong PCr signals in vivo whereas in others PCr was negligible. Of nine tumours examined in vivo, four had a significant PCr signal (PCr/PNTP = 0.64 ± 0.14) and in five it was negligible. Acid extracts of 10 tumours from a similar size range had a more uniform distribution of PCr/NTP values (mean PCr/ NTP = 0.38 ± 0.08). None of the spectral parameters measured showed any correlation with growth and similarly in the acid extracts there was no correlation between the size of tumour and either PCr, Cr, NTP or NDP (see Table III ). The pH of these tumours ranged from 7.2 to 7.7.
Because of the lack of correlation between size and any parameter measured in the Walker carcinosarcomas we studied a single tumour throughout its growth by NMR alone. This study showed that PNTP/Pi values, calculated from the NMR spectra of a tumour that increased from 1.8 to 29.5 cm3 over a period of 6 days, also did not correlate with increasing size (P>0. 1).
General comparisons between NMR and extract data Pi measured in extracts of Walker carcinosarcomas and mammary adenocarcinomas was consistently higher than that measured by NMR (Table IV) . This finding has been made in a number of normal tissues and is thought to be due to binding or compartmentalisation of Pi in vivo causing it to be NMR invisible (Ross et al., 1984; Iles et al., 1985) although in contrast Corbett et al. (1987) found more Pi in vivo than in vitro in a human melanoma grown in nude mice.
In tumours containing PCr it was possible to calculate 'free' ADP (assuming equilibrium in the creatine kinase reaction) from the extract measurements of PCr, Cr, ATP H+ (calculated from the pH measured in the NMR spectrum) and the Keq for creatine kinase (Veech et al., 1979) . The results shown in Table IV suggest that 10-20% of the total tumour ADP is 'free', a value similar in order of magnitude to that observed in kidney and liver (Freeman et al., 1983; Iles et al., 1985) .
Phosphate metabolite ratios in tissue overlying subcutaneously implanted tumours In three of the tumour types and at three or four points in the growth studies, skin tissue overlying the tumours was rapidly frozen. The data from the extracts suggest that there is some correlation between PCr/Cr and PCr/NTP ratios in the skin and the degree of skin invasion by the tumour. In the Walker carcinosarcoma and mammary adenocarcinomas, where histological evidence of skin invasion was observed more often than not, the PCr/Cr ratios were 0.44 ± 0.15 and 0.41 0.12 respectively and the PCr/NTP ratios were 0.80 0.14 and 1.98 ± 0.43 respectively, considerably lower than in normal skin (1.17 and 3.6; Stubbs et al., 1988a) whereas in the prolactinomas where skin invasion was observed only in one tumour of 17 cm3, the PCr/Cr and PCr/ NTP were higher: 1.54 ± 0.17 and 5.0 ± 1.3 respectively, both slightly higher than the normal skin range. The changes in the NTP/NDP ratios were not as clear cut but a change in this ratio would be expected to be less marked than the change in PCr/NTP due to the equilibrium position of the creatine kinase reaction (McGilvery & Murray, 1974) .
Discussion
The first tumour to be studied by NMR spectroscopy in vivo, the Walker carcinosarcoma, gave spectra that sometimes showed PCr and sometimes did The data are the correlation coefficients achieved when comparing the ratios with tumour size. The closer the coefficient is to 1 the greater the correlation between the decrease in high energy/low energy phosphate ratio compared to the increase in tumour size. The results are expressed as gmol g-' wet wt and are mean ± s.e.m. P values compare total versus free metabolites. Total ADP and Pi were measured in tumour extracts as described in the text. Free ADP was calculated from ATP, PCr, and Cr measured in tumour extracts, pH measured from the NMR spectra, and the Keq for creatine kinase according to Veech et al. (1979) . Free Pi was calculated from the PNTP/Pi ratios measured from the NMR spectra making the simplifying assumption that NTP measured in extracts was equal in concentration to the PNTP integral in the NMR spectra.
not . PCr was found in spectra of mouse tumours (Ng et al., 1982) and in human xenografts grown in mice (Griffiths & Iles, 1982) . Furthermore, Ng et al. (1982) showed that the PCr peak diminished during tumour growth and that it became larger after chemotherapy. The tumours in the present study fell into three classes with respect to their PCr content. At one extreme the Morris hepatoma 7777 showed no evidence of PCr or Cr in acid extracts; the PCr signals observed in vivo in some of these tumours (Stubbs et al., 1988a (Stubbs et al., , 1989 were presumably caused by skin contamination. The lack of PCr is probably because hepatomas, like the hepatocyte from which they arise, do not express creatine kinase (Shatton et al., 1979) .
In contrast, the GH3 prolactinomas always contained PCr and Cr in extracts and almost always showed a PCr signal in vivo (Table I ). The mammary adenocarcinomas also contained Cr and varying amounts of PCr in all extracts, but here three of the four largest tumours in a parallel series showed negligible PCr signal in vivo (Table II) .
The Walker carcinosarcomas fell into a third category. All those studied by acid extraction contained PCr and Cr but only about 50% of the NMR spectra showed signals in vivo, explaining our earlier observations Griffiths et al., 1982) .
To what extent do other tissues contribute to the NMR spectra? First, NMR spectra taken with a surface coil include signals from the tumour itself, from overlying tissues (Stubbs et al., 1988a (Stubbs et al., , 1989 ) and perhaps from underlying or laterally adjacent tissues. As skeletal muscle has an intense PCr signal, PCr in a subcutaneous tumour spectrum is particularly suspect. Under the conditions used in the present experiment we think it unlikely that the surface coil detected significant signals from underlying or laterally adjacent tissue (for discussion of this point see Griffiths et al., 1987) . Extracts from freeze-clamped skin and tumour can give specific information on the possible contribution of PCr and Cr from those compartments to the spectrum. For instance, these data can tell us whether a tumour contains creatine compounds; if it does not, any PCr signal in the NMR spectrum evidently arises from overlying tissue as in the case of some hepatomas (Stubbs et al., 1989 and this paper) . However, because the exact volume of skin that is in the field of the surface coil is difficult to quantify due to the irregular radiofrequency fields surface coils produce (Ackerman et al., 1980) it was not possible to relate the skin extract data directly to the NMR spectra. Precise localisation and quantitation techniques are needed for this.
What does the 3'P-NMR spectrum of a subcutaneously implanted tumour tell us about the status of the tumour? In three of the tumours studied here (mammary adenocarcinoma, GH3 prolactinoma and Morris Hepatoma 7777), there was a tendency for the high energy/low energy phosphate ratios to decline as the tumours enlarged (Table III) . Thus these tumours show a decline in high energy phosphates (PNTP and PCr) relative to Pi with increasing tumour size (see Glickson et al. (1989) No correlations between increasing tumour size and pH were observed in any of the tumours. Such correlations have previously been made in some tumours (Ng et al., 1982; Adams et al., 1985; Rofstad et al., 1988a Rofstad et al., , 1988b but not in others (Rofstad et al., 1988a; Ross et al., 1988; Steen et al., 1988; Rodrigues et al., 1988) .
The fall in PCr usually seen in enlarging tumours has often been attributed to PCr being used to synthesise ATP in cells that were becoming hypoxic as a result of impaired tumour circulation (Evanochko et al., 1984; Remy et al., 1987; Rofstad et al., 1988a) and this is said to compensate for the 'inefficiency' of the glycolytic pathway as a source of ATP (Rofstad et al., 1988; Evanochko et al., 1984; Remy et al., 1987; Glickson et al., 1989) .
ADP + PCr-ATP + Cr creatine kinase In practice, however, the amount of PCr in a tumour is far too small (typically 1-2jmol g' wet weight) to make a significant contribution to the ATP supply. Consider that tumour ATP turnover is probably about 6pmol min-' g-':
conversion of all the PCr would supply ATP for only 10-20 s, whereas the fall in PCr concentration actually takes place over a period of days, or even weeks.
What we observe in the 31P spectrum of a tumour is a slowly changing steady state in which the concentrations of the metabolites vary so as to maintain the maximum possible rate of ATP synthesis despite a steady fall in cellular oxygen concentration.
Do the 3'P-NMR changes that we, and others, have observed in growing tumours reflect events in all the cells of a tumour? Or do they occur only in the necrotic cells, with the remainder being unaffected? This question has some practical importance: does 3'P-NMR tell us about the proportion of the tumour that has become necrotic or does it tell us about the metabolism of viable but hypoxic cells?
We can answer these questions for tumours such as the GH3 prolactinoma and the NMU-induced mammary tumour in the present study, and also for the MOPC 104E mouse myeloma, described by Ng et al. (1982) . In all these tumours the PCr signal is lost before there is a significant fall in the NTP peaks. This is clearly inconsistent with the hypothesis that the changes occur only in cells that have become necrotic, since necrotic cells have no NTP. If the tumour consisted of normal cells with both PCr and NTP and necrotic cells with neither PCr nor NTP one would observe a synchronous fall in the PCr and NTP signals as the necrotic fraction increased in the growing tumour. This was clearly not the case in the NMU-induced mammary tumour or the GH3 prolactinoma (see PCr/NTP ratios in Tables I and II) , and in the larger NMU-induced mammary tumours PCr was undetectable despite strong NTP signals. Significant NTP resonances have been reported (Ross et al., 1988) even when there was 80-90% necrosis present in a C6 glioma, supporting the suggestion that the NMR signal comes from the viable cells.
We can conclude, for these tumours at least, that the 3'P-NMR data tell us about the metabolic changes that occur in viable cells, and thus in cells that may be the target of therapy.
